Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-21

Clinical Trial Update: Effect of Starter Formula on Infection Prevention [NA]

View source ↗

Summary

A Nestlé-sponsored trial evaluating whether starter formula reduces gastrointestinal infections and infection with fever has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Gastro-intestinal Infections, Infections With Fever | NA | Status: COMPLETED